In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.

The company's total leverage manageable. As of December 2024, Stifel had a 11.4% Tier 1 leverage ratio compared with management's previously stated target of 10%, implying that the firm is carrying ...

America's status as a global science leader is in doubt as the administration freezes funding and targets research that ...

In Bangladesh, academia is often one of the most overlooked aspects that has the potential to greatly contribute to the country’s sustainable development. With the rise in the conversation of the ...

Geoffrey Kendrick believes sovereign wealth funds will increase their exposure, spurred by the US government's growing ...

Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock To get a sense of who is truly in control of Nucor Corporation (NYSE:NUE), it is ...

When politics and fiduciary duty collide, many investors ultimately believe that fiduciary duty must win. Eric Darrisaw, ...

UGC reformulates journal parameters for HEIs, seeking feedback to enhance research quality and academic integrity in India.

Strategic Governance Advisors ("SGA"), a leading advisor to public companies which have or expect to have conflict with their ...

Asset Planning Inc acquired a new stake in Tesla, Inc. (NASDAQ:TSLA – Free Report) in the fourth quarter, according to the ...

Blue Trust Inc. lowered its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 18.2% during the fourth quarter, according to its most recent disclosure with the Securities ...